203 related articles for article (PubMed ID: 33676851)
21. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
[TBL] [Abstract][Full Text] [Related]
22. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force.
Villa S; Kendel F; Venderbos L; Rancati T; Bangma C; Carroll P; Denis L; Klotz L; Korfage IJ; Lane AJ; Magnani T; Mastris K; Rannikko A; Roobol M; Trock B; Van den Bergh R; Van Poppel H; Valdagni R; Bellardita L
Eur Urol; 2017 Feb; 71(2):274-280. PubMed ID: 27720532
[TBL] [Abstract][Full Text] [Related]
23. A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
Merriel SWD; Moon D; Dundee P; Corcoran N; Carroll P; Partin A; Smith JA; Hamdy F; Moore C; Ost P; Costello T
BMC Urol; 2021 Feb; 21(1):18. PubMed ID: 33541309
[TBL] [Abstract][Full Text] [Related]
24. Prostate focal therapy: the rule or exception?
Tay KJ
Curr Opin Urol; 2018 Nov; 28(6):512-521. PubMed ID: 30124517
[TBL] [Abstract][Full Text] [Related]
25. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
Bruinsma SM; Roobol MJ; Carroll PR; Klotz L; Pickles T; Moore CM; Gnanapragasam VJ; Villers A; Rannikko A; Valdagni R; Frydenberg M; Kakehi Y; Filson CP; Bangma CH;
Nat Rev Urol; 2017 May; 14(5):312-322. PubMed ID: 28290462
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
[TBL] [Abstract][Full Text] [Related]
27. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
[TBL] [Abstract][Full Text] [Related]
28. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
29. Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design.
van den Bos W; Muller BG; de Bruin DM; de Castro Abreu AL; Chaussy C; Coleman JA; Finelli A; Gill IS; Gross ME; Jenniskens SF; Kahmann F; Laguna-Pes MP; Rastinehad AR; Simmons LA; Sulser T; Villers A; Ward JF; de la Rosette JJ
Urol Oncol; 2015 Nov; 33(11):495.e1-7. PubMed ID: 26231310
[TBL] [Abstract][Full Text] [Related]
30. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement.
Ganzer R; Arthanareeswaran VKA; Ahmed HU; Cestari A; Rischmann P; Salomon G; Teber D; Liatsikos E; Stolzenburg JU; Barret E
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):175-186. PubMed ID: 29743538
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
32. Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").
Reis LO; Billis A; Zequi SC; Tobias-Machado M; Viana P; Cerqueira M; Ward JF
Aging Male; 2014 Jun; 17(2):66-71. PubMed ID: 24597940
[TBL] [Abstract][Full Text] [Related]
33. Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approach.
Loblaw A; Barkin J; Buckley R; Chung H; Kell J; Singal R; Spodek J; Vesprini D; Flax S
Can J Urol; 2017 Feb; 24(1):8646-8650. PubMed ID: 28263130
[TBL] [Abstract][Full Text] [Related]
34. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
Tosoian JJ; Mamawala M; Epstein JI; Landis P; Macura KJ; Simopoulos DN; Carter HB; Gorin MA
Eur Urol; 2020 Jun; 77(6):675-682. PubMed ID: 31918957
[TBL] [Abstract][Full Text] [Related]
35. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
[TBL] [Abstract][Full Text] [Related]
36. [Focal therapy of prostate cancer in Germany].
Apfelbeck M; Herlemann A; Stief CG; Gratzke C
Urologe A; 2016 May; 55(5):584-92. PubMed ID: 27142799
[TBL] [Abstract][Full Text] [Related]
37. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
38. German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Borkowetz A; Blana A; Böhmer D; Cash H; Ehrmann U; Franiel T; Henkel TO; Höcht S; Kristiansen G; Machtens S; Niehoff P; Penzkofer T; Pinkawa M; Radtke JP; Roth W; Witzsch U; Ganzer R; Schlemmer HP; Grimm MO; Hakenberg OW; Schostak M
Urol Int; 2022; 106(5):431-439. PubMed ID: 35144260
[TBL] [Abstract][Full Text] [Related]
39. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
40. Evolution from active surveillance to focal therapy in the management of prostate cancer.
Lindner U; Lawrentschuk N; Schatloff O; Trachtenberg J; Lindner A
Future Oncol; 2011 Jun; 7(6):775-87. PubMed ID: 21675840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
